Search

Lonza Group AG

Ouvert

SecteurSoins de santé

648.6 0.81

Résumé

Variation du prix de l'action

24h

Actuel

Min

640

Max

651

Chiffres clés

By Trading Economics

Revenu

88M

571M

Ventes

419M

3.4B

P/E

Moyenne du Secteur

42.068

50.373

BPA

8.45

Rendement du dividende

0.79

Marge bénéficiaire

16.924

Employés

20,141

EBITDA

321M

1.1B

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+10.99% upside

Dividendes

By Acuity

Rendement du dividende

Moyenne du Secteur

0.79%

2.12%

Prochains Résultats

27 janv. 2027

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

4.9B

44B

Ouverture précédente

647.79

Clôture précédente

648.6

Lonza Group AG Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

1 nov. 2026, 13:01 UTC

News

Michael Saylor plans to purchase additional Bitcoin, aiming to exceed 850k BTC for the first time.

31 oct. 2026, 00:02 UTC

News

Lyft, Inc. shares are advancing in after-market trading, supported by a broader market uptick.

31 oct. 2026, 00:02 UTC

Social Media
Correlated Moves
News

MSCI Inc. will continue using regular trading hours closing prices for index calculations, despite updates on trading extensions from Nasdaq and NYSE Arca.

31 oct. 2026, 00:02 UTC

Correlated Moves
News

Cantor Fitzgerald identifies buying opportunity in crypto-linked stocks, including Strategy Inc, following Binance hack, noting potential for recovery as panic subsides.

31 oct. 2026, 00:02 UTC

Correlated Moves
News

Allegro Microsystems Inc reported Q2 FY27 sales of $276.88 million and net income of $23.26 million, with shares trading higher in after-market hours.

31 oct. 2026, 00:02 UTC

News

Okta, Inc. will replace Kenvue in the S&P 500 on November 4, 2026, following Kimberly-Clark's acquisition, enhancing its visibility to investors.

31 oct. 2026, 00:02 UTC

News

DICK'S Sporting Goods faces class action lawsuits alleging securities fraud and misleading investors about financial performance following an earnings miss.

31 oct. 2026, 00:02 UTC

News
Social Media

Coinbase Global, Inc. saw an uptick in after-market trading after JP Morgan maintained its Overweight rating but lowered the price target to $187.

31 oct. 2026, 00:01 UTC

News

Mondelez International, Inc. shares traded modestly lower during after-market hours on Friday, following a decline from a brief peak earlier in the session.

31 oct. 2026, 00:01 UTC

News

Kimberly-Clark Corporation is set to acquire Kenvue, with the transaction expected to close soon, subject to final conditions.

31 oct. 2026, 00:01 UTC

News

Kraft Heinz Company shares advanced in after-market trading, reaching their highest point since Friday's close and trading near the upper end of their one-month range.

31 oct. 2026, 00:01 UTC

News

BTIG suspended its Buy rating on IDEXX Laboratories, contributing to a decline in its share price during after-market hours.

31 oct. 2026, 00:01 UTC

News

Ares Capital Corporation announced a merger agreement to acquire MidCap Financial Investment Corporation, resulting in the cancellation of MidCap's earnings call on November 5, 2026.

31 oct. 2026, 00:01 UTC

News

BWX Technologies Inc is rising in after-market trading after being selected by the U.S. Army to develop a nuclear microreactor for its $2.2 billion Janus program.

30 oct. 2026, 23:51 UTC

News

FMC Corp shares are declining in after-market hours following disappointing Q3 earnings, with an 80% revenue drop to $106 million and an adjusted loss per share of $4.41.

30 oct. 2026, 23:51 UTC

News

BTIG suspended its Buy rating on Zoetis Inc, contributing to a modest decline in the stock during after-market hours.

30 oct. 2026, 23:51 UTC

News

Stryker receives mixed analyst assessments, with Stifel lowering its price target to $325 and Citigroup adjusting to $315, both maintaining Buy ratings.

30 oct. 2026, 23:41 UTC

News

Allegro Microsystems Inc. reported Q2 FY27 sales of $276.88M, exceeding expectations, and provided Q3 guidance of $278M to $288M, with shares modestly higher in after-market trading.

30 oct. 2026, 23:41 UTC

News

BTIG suspended its Buy rating on IDEXX Laboratories, contributing to a decline in the stock's price during after-market hours.

30 oct. 2026, 23:36 UTC

News

Capri Holdings Ltd reported Q2 profit of 42 cents per share and raised full-year EPS forecast to $2.20, with shares trading lower in after-market hours.

30 oct. 2026, 23:31 UTC

News

McGrath RentCorp will replace Glaukos in the S&P 600 index at the market open on November 4, 2026, contributing to positive after-market price movement.

30 oct. 2026, 23:26 UTC

News

JP Morgan maintains its Underweight rating on T. Rowe Price while raising the price target to $107; TD Cowen lowers its target to $96.

30 oct. 2026, 23:26 UTC

News

Citigroup reaffirms Buy rating on Fortrea Holdings Inc and raises price target to $27, according to a report published today.

30 oct. 2026, 23:21 UTC

News

Compass Inc. faces a class action lawsuit from Pomerantz LLP, alleging securities fraud related to its merger with Anywhere Real Estate Inc.

30 oct. 2026, 23:16 UTC

News

JP Morgan maintains Neutral rating on Dexcom Inc and raises its price target to $85, reflecting the company's market position and growth potential.

30 oct. 2026, 23:11 UTC

News

Pomerantz LLP has filed a class action lawsuit against The Chemours Company, alleging misleading statements and violations of federal securities laws.

30 oct. 2026, 23:11 UTC

News

Cantor Fitzgerald identifies Binance's $6.3 billion hack as a potential buying opportunity for crypto-linked stocks, including Strategy Inc., amid recovery confidence.

30 oct. 2026, 23:06 UTC

News

Uranium Energy Corp. shares declined in after-market hours, reflecting broader sector pressures despite analysts noting tightening supply in the uranium market.

30 oct. 2026, 23:06 UTC

News
Social Media

S&P Global Ratings revised its outlook on Meta Platforms, Inc. to negative, citing uncertainty over capital expenditures and projected free operating cash flow deficits.

30 oct. 2026, 23:06 UTC

News
Social Media

eBay expands managed shipping program amid seller eligibility concerns.

Lonza Group AG prévision

Objectif de Prix

By TipRanks

10.99% hausse

Prévisions sur 12 Mois

Moyen 715 CHF  10.99%

Haut 770 CHF

Bas 650 CHF

Basé sur 4 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

4 ratings

4

Achat

0

Maintien

0

Vente

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Lonza Group AG

Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments. The Biologics segment engages in the contract development and manufacturing of biopharmaceuticals for clinical and commercial manufacturing needs throughout the product lifecycle, including drug substance and drug product manufacturing. The Small Molecules segment operates as an integrated development and manufacturing service provider for small molecule drug substances and their intermediates. This segment also supports customers across various aspects of design, development, and manufacturing, including particle engineering and drug product packaging. The Cell & Gene segment develops technologies and platforms that industrialize the manufacturing processes and production of cell and gene therapies; offers contract development and manufacturing services, and regulatory support for a range of allogeneic and autologous cell therapies, and exosome-based therapies, as well as viral vector gene therapies. This segment also provides Cocoon platform, a closed automated system for patient-scale cell therapy manufacturing; and specialty raw materials and enabling technology solutions in cell and gene therapy, injectable drugs, vaccines, and bio-manufacturing markets. The Capsules & Health Ingredients segment offers capsules, dosage form solutions, and health ingredients for pharmaceutical and nutraceutical customers. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.
help-icon Live chat